Monoclonal Antibody Therapy Stocks List Ranked for

Symbol	Grade	Name	% Change
CTMX	B	CytomX Therapeutics, Inc.	-1.56
MRUS	C	Merus N.V.	1.81
APGE	D	Apogee Therapeutics, Inc.	3.81
CGEN	D	Compugen Ltd.	-2.31

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
SBIO	D	ALPS Medical Breakthroughs ETF	1.77
FORH	A	Formidable ETF	1.67
PTH	D	Invesco DWA Healthcare Momentum ETF	1.65
BBC	D	Virtus LifeSci Biotech Clinical Trials ETF	1.47
CNCR	D	Loncar Cancer Immunotherapy ETF	1.38

Compare ETFs

Compare BBC to CNCR Compare FORH to BBC Compare FORH to CNCR

Date	Stock	Title
May 2	CTMX	CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
May 2	CTMX	CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
May 2	CTMX	Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 1	CTMX	CytomX surges on upcoming data for Amgen-partnered cancer drug
May 1	CTMX	CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
Apr 29	MRUS	Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Apr 29	CGEN	We're Not Worried About Compugen's (NASDAQ:CGEN) Cash Burn

Monoclonal Antibody Therapy: Monoclonal antibody therapy is a type of targeted therapy that uses monoclonal antibodies to bind to specific targets on cancer cells. These antibodies can either block the action of certain proteins on the cancer cells, or they can deliver toxins or other drugs directly to the cancer cells. Monoclonal antibody therapy is used to treat a variety of cancers, including lymphoma, leukemia, and breast, lung, and colorectal cancers.